Anti-craving agents in the treatment of addiction

Summary

The PhD students will be part of a team working on a large NHRMC funded trial of anti-craving agents in the treatment of alcohol use disorder investigating the role of genotypes in predicting treatment response. Students will use a combination of techniques depending on the specific research angle chosen including neuroimaging, clinical psychology, psychophysiology and pharmacogenetics.

Supervisor(s)

Dr Kirsten Morley

Research Location

Camperdown - Central Clinical School

Program Type

Masters/PHD

Synopsis

The project will require multidisciplinary collaboration, involving clinical trials, medicine, genetics, neuroimaging and clinical psychiatry/psychology in an integrative approach. The project will contribute to a large NHRMC funded trial of anti-craving agents in the treatment of alcohol use disorder investigating the role of genotypes in predicting treatment response. There is scope for a range of different clinical angles to investigate within this large project and students will have exposure to the dynamic mentoring program at the NHMRC CRE for Mental Health and Substance Use.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the Camperdown - Central Clinical School .

Keywords

Pharmacogenetics, neuropharmacology psychiatric genetics, Addiction, treatment, Clinical psychology, craving

Opportunity ID

The opportunity ID for this research opportunity is: 222

Other opportunities with Dr Kirsten Morley